Ministério da Saúde, Trabalho e Bem-Estar do Japão concede designação de medicamento órfão ao tagraxofusp para Neoplasia de Células Dendríticas Plasmocitoides Blásticas (NCDPB) FLORENÇA, Itália e NOVA IORQUE, 30 de agosto de 2023 /PRNewswire/ — A Menarini Group (“Menarini”), uma empresa…

El Ministerio de Salud, Trabajo y Bienestar de Japón otorga la designación de medicamento huérfano a tagraxofusp para tratar la neoplasia de células dendríticas plasmocitoides blásticas (BPDCN) FLORENCIA, Italia y NUEVA YORK, 30 de agosto de 2023 /PRNewswire/ — Menarini Group…

US$2.58 billion transaction will strengthen the Group’s balance sheet SÃO PAULO, Aug. 30, 2023 /PRNewswire/ — Natura &Co (NYSE – NTCO; B3 – NTCO3) announces that it has completed the sale of Aesop to L’Oréal for a final enterprise value of US$2.58 billion after obtaining all customary…

DUBLIN, Aug. 30, 2023 /PRNewswire/ — The “US Healthcare Technology Management Market by Service (Maintenance & Repair, Integrated software platform, Quality & regulatory compliance, Labour management, Supply chain, Cyber security), Facility Type (Acute, Post Acute, Non Acute) – US…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.